||EPS - Basic
||Market Cap (m)
|Pharmaceuticals & Biotechnology
|fishbournetrader: So the board believe that they can manage the shareholder's money better than the shareholder's can!!! I certainly haven't seen any evidence of this so far.
This company is really just a large bank balance with a small loss making business attached.
What they will actually do is slowly spend it on lining their own pockets and what we will be left with, if we are lucky, is a slightly larger business making a small profit and a share price of less than 20p.|
|lanzarote666: So a company currently worth £25m is going to get £16m cash - why is this share price not higher than the current 50p?
Some may be thinking that this is fair value because of the recent run up in the share price, but all the last seven days proves is that this is a leaky ship when it comes to price sensitive news.
|cisk: As always insider trading and shareprice manipulation - what else explains the sudden share price rise yesterday...|
|this_is_me: Why was there a frightening drop in the share price recently, followed by a rapid rise? Surely not insider dealing! Will it be investigated? !!|
|sailing john: Melo - I assume you mean the Director/PDMR VCP - but they need to hit 48.5p after results to see anything and a further 20% rise (compounded) in the share price in the following two years. So as it stands they will get nothing - it's pretty generous so I assume they are grafting hard for a raft of good news in the run up to finals so they hit the shareprice targets.
fwiw the last Director trade was a small buy in November 1m at 45p so he is currently down £45k in a couple of months.
Off the radar - no rush - I'm happy to hold (indeed added at 45p recently - a litle early with hindsight!) as balance sheet now sorted and some large supermarket contracts just about to kick in.
|johnward1234: hi eric,
it looks like lower targets have now been set for the puricore's new LITP for executives.
Under the preivous LTIP the share price had to reach £1.55 for their payouts to start.
puricore has now lowered this price target to 51.6p
Looks like to me a collapsing share price, but the executives payouts keep coming.Correct me if getting this wrong, but this threatened shareholder revolt is not working. )|
|mathewawood: At last Peel Hunt have finally put out their earnings forecasts!
I've been sending them e-mails basically telling them that the information is vital for an average investor to make the decision whether or not to invest in the company. And that along with a current buy/sell spread of 10% on the share price, the investment potential is being strangled to death by the brokers it actually pays to make investing in the company easier!
They got back to me saying it was regulations they couldn't publish. I said what regulations? ...And now this. Ha.
There earnings are roughly similar to mine. Break even 2013 and 100% EPS growth from then on. Hence stonking buy material. Can't say I've ever seen a price target 2.7X the share price
Last train departing before it multi-bags!|
|joeblogg2: Early resolution of funding/convertibles and the company re-iterating sterilox as becoming a de-facto standard bodes well for the future!!! Also, the Directors have said after contacting them some months ago the low liquidity and low no. of shares makes the share price volatile and have just checked there are approx 26mill shares in issue.|
|naiad: Market cap £11.7 million and sale of one division/product line for about £10.6 million (if it goes ahead) means the rest of the business would be valued at £1.1 million.With a placing of £1 million plus this would provide a cash fund of around £12 million + any cash already in the business. What will the cash be used for?
This should all drive the share price up when the market spots it.......or have I missed something..........for instance given this potential cash influx within say 2 months if the sale proceeds why make the placing albeit at a premium to the current share price? How shaky is the current cash position?|
|naiad: More debt based fund raising a week ago and no mention of the results. A share price which has been notching up for each of the last few days. Discussion of strategic initiatives, which have been and are on-going, which mean that the company cannot release its results. And all of this such that the announcement of the results is pulled on the morning they are due.
What makes results uncertain to the point they cannot be released? Valuation of income streams, going concern doubts, technical failure of the product with potential claims. All possible but would have been known about and this last minute action would not be necessary. If a bid had been received it would have to be released if it was such as to be taken seriously. If however the results coming out are poor, and the company has started discussions about a merger, would the delay in issuing results protect shareholders against selling when the value of their shares might increase due to a possible merger or other transaction. Would protecting the share price through suspension improve the relative value Puricore shareholders get if a transaction follows.
This is all very curious and disconcerting in a company that has consistently failed to deliver shareholder value.|
Puricore share price data is direct from the London Stock Exchange